Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
prostate cancer
Biotech
Radiopharma biotech Artbio paints path to clinic with $132M
Funds will support Artbio's lead prostate cancer asset through phase 2 as well as efforts to boost its radioisotope supply chain.
Darren Incorvaia
Jul 29, 2025 7:30am
Research non-profit acquires embattled Essa in Xoma-backed deal
Jul 14, 2025 9:30am
Nuclidium raises $99M for copper-based radiopharma pipeline
Jul 10, 2025 5:04am
J&J shares survival data on KLK2 bispecific in prostate cancer
Jun 2, 2025 6:40am
Juri inks $210M T-cell engager deal with China biotech
May 27, 2025 6:00am
Biopsies illuminate potential of Candel's prostate cancer drug
May 22, 2025 6:57pm
